The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth (Q81580780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jesus Gil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Didier Monté

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tapio Visakorpi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

P Dumont

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

S Rizzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

B Quatannens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

D Hudson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

F Fuks

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Y de Launoit

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1358-1366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

Molecular genetics of prostate cancer.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Myc confers androgen-independent prostate cancer cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

DNA methyltransferases get connected to chromatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Lack of RB protein correlates with increased sensitivity to UV-radiation-induced apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

p53 oncogene mutations in three human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Preferential response of cancer cells to zebularine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Prostatic carcinoma: histological and immunohistological factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

A history of prostate cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Emerging connections between DNA methylation and histone acetylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Strategies for reversing drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

A census of human cancer genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

DNA methyltransferase inhibitors-state of the art.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Identification of c-MYC as a target of the APC pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

DNA methylation in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Polycomb complexes and silencing mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

1 reference

7 January 2021

MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Molecular mechanisms of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Deficiency of Mbd2 suppresses intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Tumor p53 status and response to topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

The molecular genetics of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Myc activates telomerase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Transcriptional regulation of prostate kallikrein-like genes by androgen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Histone deacetylase as a new target for cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209179

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16331274%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 January 2020

1004035368

0 references

1 reference